These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9226008)
1. 99mTc-sestaMIBI breast scintigraphy. Colella AC; Scopinaro F; Schillaci O; Danieli R; De Vincentis G; Ierardi M; Tavolaro R Tumori; 1997; 83(2):520-2. PubMed ID: 9226008 [No Abstract] [Full Text] [Related]
2. Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions. Sanidas EE; Koukouraki S; Velidaki A; Manios A; Stathopoulos E; De Bree E; Kafousi M; Kodogiannis E; Karkavitsas N; Tsiftsis DD Nucl Med Commun; 2003 Mar; 24(3):291-6. PubMed ID: 12612470 [TBL] [Abstract][Full Text] [Related]
3. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Scopinaro F; Schillaci O; Scarpini M; Mingazzini PL; Di Macio L; Banci M; Danieli R; Zerilli M; Limiti MR; Centi Colella A Eur J Nucl Med; 1994 Sep; 21(9):984-7. PubMed ID: 7527779 [TBL] [Abstract][Full Text] [Related]
4. [Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer]. Mulero F; Nicolás F; Castellón MI; Claver MA; Abad L; Nuño de la Rosa JA Rev Esp Med Nucl; 2000 Oct; 19(6):416-22. PubMed ID: 11060271 [TBL] [Abstract][Full Text] [Related]
5. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer. Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions. Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457 [TBL] [Abstract][Full Text] [Related]
7. Breast-specific gamma imaging for detection of breast cancer. Riordan W Radiology; 2009 Apr; 251(1):306; author reply 306. PubMed ID: 19332861 [No Abstract] [Full Text] [Related]
8. [The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer]. Qu X; Wang Y; Chen D; Li C Zhonghua Wai Ke Za Zhi; 1999 Jan; 37(1):41-3. PubMed ID: 11829776 [TBL] [Abstract][Full Text] [Related]
9. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings. Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876 [TBL] [Abstract][Full Text] [Related]
10. Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy. Papantoniou V; Tsiouris S; Koutsikos J; Sotiropoulou M; Mainta E; Lazaris D; Valsamaki P; Melissinou M; Zerva C; Antsaklis A Nucl Med Commun; 2006 Nov; 27(11):911-7. PubMed ID: 17021432 [TBL] [Abstract][Full Text] [Related]
11. Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy. Hod N; Mindlin L; Horne T Isr Med Assoc J; 2003 Apr; 5(4):296-7. PubMed ID: 14509141 [No Abstract] [Full Text] [Related]
12. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [TBL] [Abstract][Full Text] [Related]
13. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions. Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of (99m)Tc- MIBI for breast carcinoma in correlation with mammography and sonography. Tunio MA J Coll Physicians Surg Pak; 2010 Apr; 20(4):289; author reply 289-90. PubMed ID: 20392413 [No Abstract] [Full Text] [Related]
15. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma. Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092 [TBL] [Abstract][Full Text] [Related]
16. The use of technetium-99m sestamibi to indicate breast cancer invasiveness. Bourgeois P Eur J Nucl Med; 1995 Jun; 22(6):581-5. PubMed ID: 7556307 [No Abstract] [Full Text] [Related]
17. Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients. Perre CI; Rütter JE; Vos PA; de Hooge P Eur J Surg Oncol; 1997 Apr; 23(2):142-4. PubMed ID: 9158189 [TBL] [Abstract][Full Text] [Related]
18. Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide. Chiti A; Maffioli LS; Agresti R; Spinelli A; Savelli G; Casteliani MR; Giovanazzi R; Greco M; Bombardieri E Tumori; 1997; 83(2):537-8. PubMed ID: 9226013 [No Abstract] [Full Text] [Related]
19. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities. Waxman AD J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353 [No Abstract] [Full Text] [Related]
20. Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast. Ohta H; Yamamoto S; Ukikusa M; Awane H; Shintaku M; Irie K Clin Nucl Med; 1997 Aug; 22(8):553-4. PubMed ID: 9262903 [No Abstract] [Full Text] [Related] [Next] [New Search]